Biochemical Biomarkers and Neurodegenerative Diseases

• Eará dahkkit: Ciaccio, Marcello (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
• Fáttát: Medicine; Neurosciences; GLUT3; cerebral ischemia; MCAO; resveratrol; astrocytes; AMPK; amyotrophic lateral sclerosis; GSK3β; neurodegenerative disease; PD; Arylsulfatase A; lysosomes; GWAS; Gaucher's disease; prognostic biomarker; focused ultrasound; MR-guided focused ultrasound; high-intensity focused ultrasound ablation; magnetic resonance imaging; image quality; stereotaxic techniques; essential tremor; Alzheimer's disease; amyloid precursor protein; Tyr682 residue; YENPTY motif; Fyn tyrosine kinase; amyloid beta; ALS; biomarker; beta amyloid; AD; biomarkers; SARS-CoV-2; neuroinflammation; neurodegenerative nisease; nervous system; Alzheimer's Disease; Vitamin D; 25(OH)D levels; Vitamin D deficiency; inherited neuromuscular disorders; rare diseases; multiple sclerosis; genetic; polymorphisms; FOXP3; GATA3; vitamin D; neuromelanin; nigrosome-1; iron; radiomics; neurodegenerative diseases; Parkinson's disease; parkinsonian disorders; n/a
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

In this book, we collected scientific articles, including reviews and research articles, showcasing the lastest literature on the importance of biochemical biomarkers in the management of neurodegenerative diseases, from screening to diagnosis, prognosis, and treatment.